Journal Report

Digestive diseases (Basel

Download PDF
Journal Information
Journal Title
Digestive diseases (Basel
Publisher
ISSN
0257-2753
E-ISSN
Database
AERES
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Prediction of Subsequent Acute-on-Chronic Liver Failure After a 24-Hour Landmark in Cirrhotic Patients With Variceal Upper Gastrointestinal Bleeding: A Multicenter Retrospective Cohort Study
Hui Xie, Jing Chen, LingGuang Shen et al.
2026-11-7
DOI: 10.1159/ddi/acnag017
Primary Sclerosing Cholangitis in Inflammatory Bowel Disease: A 20-Year Cohort Study of Clinical Features and Transplant-Free Survival
Vali Aliyev, Oguz Kagan Bakkaloglu, Tugce Eskazan et al.
2026-11-7
DOI: 10.1159/ddi/acnag018
Global, Regional and National Burden and Temporal Trends of Gastroesophageal Reflux Disease, 1990 to 2021 and forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2021
Claire Chenwen Zhong, junjie huang
2026-11-6
DOI: 10.1159/ddi/acnag016
Effects of Bifidobacterium-based interventions on patients with irritable bowel syndrome: a systematic review and meta-analysis of randomized clinical trials
Hongkai Chang, Huixin Song, Lubo Shi et al.
2026-11-5
DOI: 10.1159/ddi/acnag015
Retraction Statement
2026-10-23 Pages 1-1
DOI: 10.1159/ddi/acnag013
Self-management strategies for symptom burden in primary biliary cholangitis are associated with improved health-related quality of life
Renate Wisse, Kristina Sokolovic, Johannes Wiegand et al.
2026-10-20
DOI: 10.1159/ddi/acnag014
Incidence Trends and Projections of Major Gastrointestinal Cancers in the United States: A SEER-Based Analysis From 2000 to 2022
Said Yaseen, Hamza Khoursheed, Ahmed S.A. Osman et al.
2026-10-9 Pages 1-1
DOI: 10.1159/ddi/acnag010
Maintenance of Efficacy Outcomes at Week 52 among Etrasimod Induction Responders: An Analysis from the Phase 3 ELEVATE UC 52 Trial
Bruce Sands, Marla Dubinsky, Brian G Feagan et al.
2026-10-8
DOI: 10.1159/ddi/acnag011
Is Pylera® Still Effective and Safe in Patients Infected by Helicobacter pylori? A 6-Year, Multicentre, Real-Life Study
Francesco Di Mario, Marilisa Franceschi, Walter Elisei et al.
2026-10-7 Pages 1-1
DOI: 10.1159/ddi/acnag012
Erratum
2026-9-29 Pages 1-1
DOI: 10.1159/ddi/acnag009
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 8, 2026 01:26